Morgan Stanley lowered the firm’s price target on Avantor (AVTR) to $27 from $28 and keeps an Overweight rating on the shares. Avantor had an “in line print” as return to growth in LSS / Bioprocessing recovery was offset by U.S. semis weakness, the analyst tells investors in a post-earnings note.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR: